Christophe Lacroix - ‘Our challenge is to culture anaerobic bacteria’

PharmaBiome, a pre-clinical stage spinoff from the ETH Zurich, has developed unique technologies to access the entire range of intestinal bacteria for the design and production of function-based consortia at scale.
We met Christophe Lacroix, Founder of Pharmabiome, during the fourth edition of Microbiome Movement Drug Development Europe held in London.
Register to take full advantage of MicrobiomePost‘s features: bit.ly/2Sb2MCD
Follow us on social media
Facebook: / microbiomepost
Twitter: / microbiomepost
LinkedIn: / microbiomepost

[@JaXuun]

This will change the world